Evidence map›Paper›PMID 41670906›Full record

ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2026

Repeat ablation strategies in atrial fibrillation patients with durably isolated pulmonary veins: insights from the Netherlands Heart Registration.

Federico Tancredi Magni, Michelle Samuel, Bart A Mulder, Michelle van der Stoel, Rutger J Hassink, Serge A Trines, Michiel J B Kemme, Jippe C Balt, Pepijn H van der Voort, Justin G L M Luermans and 2 more

Abstract read
In one paragraph

Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Making variation visible.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Federico Tancredi MagniDepartment of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Michelle SamuelDepartment of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Bart A MulderDepartment of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Michelle van der StoelNetherlands Heart Registration, Utrecht, The Netherlands.
Rutger J HassinkDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Serge A TrinesDepartment of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, The Netherlands.
Michiel J B KemmeDepartment of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Jippe C BaltDepartment of Cardiology, St. Antonius Hospital, Utrecht, The Netherlands.
Pepijn H van der VoortDepartment of Cardiology, Catharina Hospital, Eindhoven, The Netherlands.
Justin G L M LuermansDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Jonas S S G de JongDepartment of Cardiology, Hospital Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
Yuri BlaauwDepartment of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. y.blaauw01@umcg.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsIn 15-40% of patients undergoing repeat ablation for AF recurrence, all pulmonary veins (PVs) are durably isolated. Currently, there is limited evidence on the appropriate treatment strategy for these patients. We aimed to characterize and compare the effectiveness of different re-ablation strategies.

methodsAll patients referred for repeat AF ablation with all PVs durably isolated at 8 hospitals in the Netherlands were included [Netherlands-Heart-Registration (NHR); 2016-2019]. NHR data were were used to determine the presence of PV-reconnection, the ablation strategy used, and the outcome of ablation (atrial arrhythmia recurrence > 30 sec.). The effectiveness of ablation strategies was assessed with multivariable Cox models.

resultsOf 2311 repeat AF ablations performed, 274 (11.9%) patients had all PVs durably isolated. Median age was 66 (IQR:58-70) years, 44.2% women, 45.6% had persistent/long-standing-persistent AF. In 33 (12.0%) patients, no ablation was performed. A single ablation strategy was performed most often (41.2%). Posterior wall ablation (58.4%) was performed most often, followed by PV-antralization (26.3%). Over 2.0 (1.0-3.3) years, 147 (59.8%) patients had an atrial arrhythmia recurrence, and 30 (12.7%) patients had another repeat AF ablation within 1 year. After multivariable adjustment, no difference in atrial-arrhythmia recurrences was detected between individual ablation strategies, number of strategies performed, and type of atrial-arrhythmia (p > 0.05 for all). Left-atrial-volume-index was associated with a higher recurrence-risk [aHR 1.03(95%CI 1.01-1.05)].

conclusionIn patients with durably isolated PVs, a high proportion experienced recurrence of atrial arrhythmias, with no difference in recurrence rates between different re-ablation strategies.

Indexed as

Atrial fibrillationCatheter ablationDurably isolated pulmonary veinsRegistryRepeat ablation

Identifiers

PMID41670906
PMCPMC12920987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.